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Abstract
Background: Human Papilloma Virus (HPV) is a sexually transmitted cause of
carcinoma of the cervix. An important determinant of the success of a primary
preventive strategy like HPV vaccination is the knowledge and willingness of parents
to vaccinate adolescents before sexual debut.
Materials and methods of study: A cross sectional descriptive survey of mothers
of girls in 8 secondary schools in Ilorin was carried out from February to April
2015. Schools were selected using multi staged sampling. Descriptive and inferential
statistics were performed with Chi Square and ANOVA.
Results: There were 470 questionnaires returned for analysis out of 600, giving a
response rate of 78.3%. One hundred and sixty-one (34.3%) knewHPV to be sexually
transmitted infection and 40.4% knew it was the cause of cervical cancer. While
35.1% were aware of HPV vaccine, only 1.9% had ever vaccinated their children.
Less than half (44.9%) were willing to vaccinate their children. Women with good
knowledge of HPV and cervical cancer were more willing to vaccinate their children
than women with poor knowledge (P <0.001).
Conclusion: There is poor knowledge of HPV and practice of vaccination among
mothers in llorin. Willingness of mothers to vaccinate their daughters is suboptimal.
Mother’s knowledge is an important determinant of HPV vaccination of adolescents.
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1. INTRODUCTION
The global burden of cervical cancer has reached epidemic rates and as such calls for
primary prevention especially in areas of high prevalence. Carcinoma of the cervix
is the leading gynecological cancer in our environment and the second commonest
female cancer worldwide [1]. It is responsible for over 8,000 deaths annually from
advanced disease and late presentation [2, 3].
Studies have shown that many of our women are aware of the disease and there
is an increasing level of awareness about its prevention through screening for its pre-
malignant state. A survey conducted among women seeking gynecological and family
planning services in University of Ilorin Teaching Hospital (UITH), showed that 78.2% of
the respondents were aware of cervical cancer, half of them knew it can be prevented
but over two-thirds had no idea of the cause [4]. Similarly, there is a higher prevalence
of Human Papilloma Virus( HPV) infection in women with cervical lesions than those
not affected [5].
The discovery of the etiological role of the sexually transmitted HPV in carcinoma
of the cervix has re- directed the preventive strategies towards vaccination against
the virus before exposure to the infection [6]. The vaccination of pre-pubertal girls
and women of 12-26 years is the current primary preventive strategy in lime light; this
has by no means de-emphasized screening for the pre malignant state of the disease.
Unfortunately, knowledge and practices concerning the HPV infection and prevention;
its effect and role in the primary prevention of cervical cancer are very low and not
encouraging [4, 7]. Estimates suggest that introducing HPV vaccination at 12 years
of age alongside the current U.S. screening program for cervical cancer could reduce
lifetime cervical cancer incidence by up to 94% [8].
The safety and efficacy of prophylactic HPV vaccines against types 16, 18 , 11,6
and even 16/18 related CIN2/3 and adenocarcinoma in situ are well established [9–
11]. Worldwide, the available preparations of the prophylactic vaccines are expensive
and there is need to educate the populace on the importance and justify the long term
cost effectiveness.
In the United Kingdom, United States of America, Netherlands, some parts of Aus-
tralia and New Zealand, HPV vaccine has been included in the school vaccination pro-
gram for girls. In the developed world, studies have shown the varying attitudes of
parents and guardians towards HPV vaccination of their children and wards; this is not
unrelated to the general pervasive lack of knowledge of HPV as a Sexually Transmitted
Infection (STI) and a cause of cervical cancer [12].
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An important determinant of uptake of this primary prevention strategy is the atti-
tude and willingness of parents of these girls to the vaccine. Their knowledge remains
an important pivotal to acceptance of the vaccine.
In a developing society like ours most vaccination programmes are highly subsidized
or provided freely by donor agencies, in order to have a wide coverage. HPV vaccine
has not yet been subsidized. The socioeconomic capacity of parents may also deter-
mine acceptability [5] as documented by Dahlstrom et al in a population based survey
in Sweden [12]. Since the vaccine is currently available for girls below 18 years, parents
have to give consent for the child to be vaccinated. Parental knowledge and attitude
would influence parental willingness which will indirectly translate to the uptake of
the vaccine.
Baseline data are therefore necessary for national and local awareness and cam-
paign programmes to ensure the acceptability and uptake of the vaccine.
This study was to determine the knowledge of parents about HPV infection, their
awareness about HPV vaccine and willingness to vaccinate their daughters. Hopefully,
it would be an important foundation for the incorporation of HPV vaccine into the
National Immunization Programme in Nigeria.
2. MATERIALS AND METHODS
This was a cross sectional descriptive survey involving mothers of selected secondary
school girls. It was carried out in Ilorin from February to April 2015. Ilorin is the capital of
Kwara State in Nigeria. It is located in the North central geopolitical zone of the country.
It has three local government areas and the settlement is semi-urban. The main ethnic
groups in the city are Yorubas, Fulanis and Hausas.
The sample size was determined by Fischer’s formula using a prevalence rate of
14% according to Nnondu et al,7 20% of the calculated sample size was added to
cater for incomplete and non-responses. The minimum sample size calculated was
250 participants (parent/daughter pair).
The list of the registered secondary schools in Ilorin was obtained from the State
Ministry of Education after obtaining permission from theMinistry and ethical approval
from the Ethical Review Board of the University of Ilorin Teaching Hospital, Ilorin. A
multi stage sampling method was utilized to select secondary schools from the list of
schools which included both public and private secondary schools.
At the selected schools, girls between 10 and 15 years were randomly selected from
Junior Secondary Classes of these schools until the calculated sample size was reached.
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A minimum of 40 girls were randomly sampled from each school. Their parents were
invited to participate voluntarily in the study during open / visiting days for the board-
ing students while invitations were sent through the day students to their parents. The
invitation included an information sheet, consent form and the questionnaire. A week
after the distribution, the researchers returned to collect the completed questionnaires
from the girls through their class teachers.
The instrument for this survey was a close ended (multiple choice) self administered
questionnaire designed to determine the knowledge, attitude and willingness of par-
ticipants to HPV vaccination. The study respondents were assured of anonymity and
confidentiality and first part of the questionnaire provided socio-demographic infor-
mation of the mothers. The second part assessed their knowledge of HPV infections,
vaccines and their willingness to accept HPV vaccine for daughters. There was no
health education on the subject for the participants before completion of the ques-
tionnaire. Mothers completed the survey items for this study only once, even if they
had more than 1 child enrolled in the schools. The questionnaire was pre-tested in a
similar population for validity and reliability using 20% of the calculated size.
Data analysis was done using SPSS version 20 with both descriptive and inferential
Statistics. In particular, Chi-square statistics were used to estimate the degree of cor-
relation between the variables and nature of the independent variables in this study.
P values less than 0.05 were considered significant.
3. RESULTS
3.1. Socio-demographic characteristics of respondents
Six hundred questionnaires were distributed to mothers of female students from
selected secondary schools however, 470 questionnaires were returned for analysis,
giving a response rate of 78.3%.
Majority of the respondents (61.9%) were between 31 and 50 years, 83.6% were
of Yoruba ethnicity. The parents were either Christians or Muslims and 58.1% had at
least secondary school education. Among the respondents, 70.2% were employed out
of which 171(51.8%) were civil servants. Among the 91.9% of the respondents whose
social class could be determined, 22.8% (107) belonged to the upper social class. (Table
1).
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3.2. Knowledge of HPV infection
One hundred and sixty-one (34.3%) of the respondents knew that HPV can be sexually
transmitted and 34.5 percent knew that it could be prevented by use of condoms. Sex-
ual abstinence and having one sexual partner were suggested as preventive measures
for HPV infection by 27.9% and 37.7% of the respondents, respectively. Even though
40.4% knew that HPV can cause cervical cancer, a higher percentage of 47.7% did not
know that HPV can cause cervical cancer (Table 2).
3.3. Knowledge of HPV vaccine
Out of the study participants, 35.1% were aware of HPV vaccine and majority (58.7%)
has not heard of the vaccine. The hospital/medical personnel were the sources of
information in 28.1% while other sources such as mass media, health talks, journal/-
magazines accounted for approximately 15-21% (Table 3).
HPV vaccine was known to prevent HPV infection by only 29.1% of the respondents,
25.5% knew it prevented cervical cancer while only 9.6% knew it could prevent genital
warts (Table 3).
Among the respondents, 33.8% knew it was available in Nigeria. As many as 83%
of the respondents gave no response about the available types of HPV vaccine but
15.3% had no knowledge whatsoever about the types of vaccine.
Among the study participants, only 1% knew that Cervarix and/or Gardasil are HPV
vaccines, while two mothers wrongly considered the routine immunization schedule
as the vaccine.
Some respondents, 32.3% answered that all girls should be vaccinated while 6.4%
thought otherwise; 11.3% responded that it should be given to only sexually active
girls and 1.1% opined that boys should also be vaccinated.
4. PRACTICE ANDWILLINGNESS TO ACCEPT HPV IMMUNIZA-
TION
Majority (91.9%) of the parents responded that their girls have not been immunized
with HPV vaccine. Of the 9 respondents (1.9%) whose children have been immunized,
immunization was given between 11and 20 years in 77.8% of them. Among the 7%
of women that knew HPV immunized persons, only few (2.3%) reported abdominal
cramps, body pains, lethargy as side effects of the vaccine in them (Table 4).
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In this survey, 44.9% of the women were willing to vaccinate their children with
HPV vaccine even when only 13% had enough information to decide on acceptance
of the vaccine. Furthermore, 37.9% would like further consultation with a doctor or
any health care provider before accepting the vaccine. In terms of cost, 22.3% would
accept the vaccine only if free, 33. % of the respondents will do so even if vaccine
is not free. One hundred and fifty two (32.3%) of the respondents are willing to give
the vaccines to all girls while 11.3% of them would be willing to give the vaccine to
sexually active girls only (Table 5).
Respondents that were willing to vaccinate their girls had a mean score of 5.00
±3.32 about the knowledge of HPV while those not willing had a score of 4.92± 2.93.
Similarly, the knowledge score of HPV Vaccination was higher among half of those
willing to vaccinate and it was significant statistically (P 0.0001) Tables 6&7.
5. DISCUSSION
The age distribution of the study population ranged from the highly reproductive age to
peri-menopausal age; most respondents were between 31 and 50 years. Their demo-
graphic characteristics showed a variation in terms of age, education, marital status,
social class among others. Mothers in the upper social class were the least when com-
pared with those in the lower and middle classes. This is most likely a representation
of the semi-urban pattern of the population of Ilorin, Nigeria. There was poor knowl-
edge of HPV infection and practice of vaccination among mothers. The willingness to
accept HPV vaccinewas low and therewas a significant statistical relationship between
acceptability of HPV vaccine and knowledge of HPV infection, vaccination and cervical
cancer.
6. KNOWLEDGE OF HPV INFECTION AND VACCINE
The mothers of girls in this study demonstrated poor knowledge of Human papillo-
mavirus infection and vaccine as 34.5% of the respondents had a score of 5 or more
(correct knowledge).This is similar to findings from some developing countries [13–17].
For example, in Ghana and Cameroon, parents of adolescents had poor knowledge of
HPV and its vaccination [16, 17]. Our findings indicate that women in Ilorin are poorly
informed about HPV and cervical cancer, this is similar to those of other developing
countries.
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This is however, in contrast to findings among Cameroonian adolescents who dis-
played high level of awareness on HPV, cervical cancer and HPV vaccine [18]. Prior
sensitization and health education was found to result in the high level of awareness
among the girls when compared with the poor knowledge and awareness among
mothers in our study. Also, standard educational script on risk factors and prevention of
HPV infection and cervical cancer was given to the women that participated in a similar
survey in Zambia and this positively influenced their acceptability of the vaccine [14].
Education on HPV and cervical cancer prevention would increase access to screening
and other preventive measures [19]. It was concluded that community education was
the effective strategy for acceptability of HPV immunization in the setting.
The practice of HPV vaccination was very low in this study; poor knowledge of the
vaccine and the role of the virus in the widely prevalent cervical cancer in the envi-
ronment is a contributory factor. In addition to the poor knowledge of the etiological
role of HPV in carcinoma of cervix, majority knew little to nothing about availability
and types of HPV vaccines. This is rather unacceptable, knowing that the vaccine has
been licensed for use in the U.S.A, since 2006 [20] and has even become part of some
national immunization programs in both developing and developed worlds [10, 11, 14,
15, 19, 20]. This probably explains the very low percentage of HPV immunized girls in
this study.
The roles HPV vaccines in the prevention of cervical cancers and genital warts are
well established. Cervarix is a bivalent HPV vaccine that prevent HPV types 16 and 18
serotypes responsible for 70% of cervical cancers. The other quadrivalent HPV vaccine
is Gardasil. It prevents HPV types 6, 11, 16 and 18. HPV 6 and 11 cause 90% of geni-
tal warts. Gardasil also protects against cancers of the anus, vagina and vulva. WHO
recommends that settings like Nigeria where there is high prevalence and mortality
from cervical cancer should include HPV vaccines into routine national immunization
programmes [21]. The role of governmental policy in the implementation of the vac-
cine is relevant as some women even reported it wrongly as being part of the current
national immunization programme in Nigeria.
More women knew that it can prevent cervical cancer while 9.6% knew it prevents
genital warts. It may be that the awareness on cervical cancer is greater than genital
warts in our environment because of its high prevalence and associated mortality
and morbidity. However, it may be more important to educate the populace on the
role of HPV in other gynecological and anogenital cancers; its mode of spread and
transmission which is of more public health importance [10, 20].
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In addition, there was significant relationship between practice and knowledge of
the vaccine. Obviously, health education programs on the condition are either lacking
or the education is not targeted at the population at risk.
The willingness to accept HPV vaccine was low and there was a significant statistical
difference between acceptability and knowledge of HPV infection and vaccination, and
cervical cancer. Where others reported high acceptability [18-24] 44.9% of mothers
indicated willingness to accept the vaccine despite the poor knowledge. Most likely,
differences in methodology, prior health education on risk factors and prevention of
HPV and cervical cancer before survey and differing study populations are reasons for
differences between vaccine acceptability. Thus, health education programmes on HPV
infection as a risk factor for cervical cancer and other important related public health
matters should form the core strategy for implementation of HPV vaccine in our society
and not just merely making the vaccines available.
Another obvious problem with the acceptance of any vaccine is the cost. Approxi-
mately, one third of the women were willing to vaccinate their daughters even if the
vaccine is not free while a lower percentage of 22% would accept it only if free. A
related survey among Kenyan women showed that most would prefer making the
vaccine much lower cost if not free [13]. In Israel, cost of the vaccine was identified as
one of the barriers to acceptability of the vaccine among others [2]. Currently Currently,
HPV vaccines (Gardasil and Cervarix) are available in Nigeria but their cost is not within
reach for an average Nigerian; it is about the recommended minimum wage of any
employee in the country, implying that it is unaffordable by majority.
Although undocumented verbal reports are suggesting that more women are
requesting to be immunized, it is costly, not affordable and not within reach of all
women especially when compared with other vaccine preventable diseases. Until,
HPV vaccine is implemented as a national programme, it may never have wide
coverage and may never be available to adolescents at future risk of cervical cancer.
This strategy would eliminate cost as a factor that may limit the acceptability and
willingness of parents to vaccinate their wards and children.
7. CONCLUSION
One third of the respondents had correct knowledge of HPV infection, immunization
and its role in prevention of cervical cancer; 44.9% of the mothers were willing to
vaccinate, while 10.6% were not. 41.3% did not respond probably because of the poor
knowledge of HPV. This study has demonstrated the relationship between knowledge
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VARIABLE FREQUENCY (N=470) PERCENT
Age group (years)






















< Secondary school 159 33.8
Secondary or equal 99 21.1














Single mothers 105 22.3
Number of children of respondents
1 15 3.2
2 42 8.9
≥ 3 316 67.2
T 1: SOCIO-DEMOGRAPHIC PARAMETERS OF RESPONDENTS.
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VARIABLE FREQUENCY (N=470) PERCENT
HPV is sexually transmitted
Yes 161 34.3
No 66 14.0
I don’t know 186 39.6
NR 57 12.1
HPV can be prevented by use of condom
Yes 162 34.5
No 77 16.4
I don’t know 169 36.0
NR 62 13.2




I don’t know 169 36.0
NR 66 14.0
HPV can be prevented by abstinence from sex
Yes 131 27.9
No 72 15.3
Cervical cancer is caused by HPV
Yes 190 40.4
No 30 6.4
I don’t know 224 47.7
NR 26 5.5
T 2: RESPONDENTS’ KNOWLEDGE OF HPV.
of HPV, willingness and acceptability of HPV vaccines in a semi-urban population in
Nigeria, a developing country with high prevalence and mortality from cervical cancer.
There is poor knowledge of HPV and its vaccines among mothers in Ilorin; and they
are important determinants of acceptability/ willingness of parents to vaccinate their
pre-pubertal girls.
A core preventive strategy is the implementation of the vaccine into National Immu-
nization program after adequate and widespread community education. Addressing
DOI 10.18502/sjms.v13i1.1687 Page 42
Sudan Journal of Medical Sciences Kikelomo T. Adesina et al
VARIABLE FREQUENCY (N=470) PERCENT





Mass media 61 21.4
Hospital/medical personnel 80 28.1
Newspaper/journals/magazines 43 15.1
Health talk 60 21.1
Peer group/parents 11 3.9
Others
Internet 18 6.3
Relativ es 2 0.7













I don’t know 261 55.5
NR 76 16.2
Is HPV available in Nigeria?
Yes 159 33.8
No 69 14.7
I don’t know 151 32.1
NR 91 19.4
What type of HPV do you know?
None 72 15.3
Abnormal Pap’s 1 0.2
Gardasil&cervarix 3 0.6
Cervarix 2 0.4
Dpt, Bsg, Oral polio 1 0.2
Mycotine 1 0.2
NR 390 83.0
NR: No Response *multiple responses
T 3: RESPONDENTS’ KNOWLEDGE OF HPV VACCINE.
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If yes, at what age? (n = 9)
11 – 20yrs 7 77.8
> 20yrs 2 22.2




I don’t know 98 20.9





I don’t know 12 2.6
10 2.1
NR: No Response
T 4: PRACTICE OF HPV VACCINATION AMONG RESPONDENTS.
mothers of adolescent girls would be a desirable target population for implementing
other primary preventive measures such as screening for premalignant condition, HPV
infection and STIs.
8. Recommendations
There is need for intense public campaigns and enlightenment programmes on cervical
cancer, HPV and immunization to prevent cervical cancer. Without this, the reduction
in cervical cancer mortality may not be realized in the nearest future.
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VARIABLE FREQUENCY (N=470) PERCENT
HPV vaccine should be given to all girls 152 32.3
It should be given to sexually active girls only 53 11.3
HPV vaccine should be given to boys 89 1.1
I have enough information to decide for or
against accepting the vaccine for my child
61 13.0
I need to ask doctor or health worker before
accepting vaccine
178 37.9
Are you willing to vaccinate your child? 211 44.9
Willing only if vaccine is free 105 22.3
Willing even if vaccine is not free 148 31.5






Yes 211 5.00 ± 3.32𝑎 65.922 <0.001
No 50 4.92 ± 2.93𝑎
I don’t know 194 1.69 ± 2.71𝑏
F: ANOVA (Analysis of Variance); *: Statistically significant (i.e. p value <0.05); Mean
with different alphabets indicate significant difference
T 6: Mean score of respondents’ knowledge of HPV and willingness to vaccinate child.
This should be foremost if any HPV immunization programme would be successful
in our environment. The cost of the vaccine should be heavily subsidized if not made
freely available by the government. The long term benefits are worthwhile.
Willingness to vaccinate child
Knowledge
score
Yes No I don’t know Total 𝜒2 p value
n (%) n (%) n (%) n (%)
0 – 4 106(50.2) 24(48.0) 168(86.6) 298(65.5) 69.118 <0.001*
5 – 9 78(37.0) 22(44.0) 22(11.3) 122(26.8)
≥ 10 27(12.8) 4(8.0) 4(2.1) 35(7.7)
Total 211(100.0) 50(100.0) 194(100.0) 455(100.0)
T 7: Relationship between willingness to vaccinate child and the respondents’ knowledge of HPV and
vaccination
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9. Limitation
This surveywas conducted amongmotherswhowere reached through their daughters
and not a community based survey which would have identified mothers directly.
There was no preceding health education on the subject like earlier similar sur-
veys which probably explains the high poor response to many questions. In another
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16. List of Abbreviations
HPV Human Papilloma Virus
U.I.T.H University of Ilorin Teaching Hospital
U.S.A United States of America
CIN Cervical Intraepithelial Neoplasia
STI Sexually Transmitted Infection
SPSS Statistical Package for Social Sciences
WHO World Health Organization
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